India

Will India Issue a Compulsory License for an AstraZeneca Diabetes Pill?
WSJ Pharmalot
Thu, 07/9/15 - 10:28 am
India
diabetes
AstraZeneca
Gleevec
Another Indian CRO in hot water, this time with the WHO
BioPharma Dive
Thu, 07/9/15 - 09:55 am
India
CROs
Quest
Dr Reddy's Laboratories working on 18 new drug applications for FDA
Economic Times, India
Mon, 06/22/15 - 11:07 am
FDA
India
Dr Reddy's
Biosimilar of Novartis' eye drug Lucentis launched in India
Fierce Pharma
Fri, 06/19/15 - 05:13 pm
Novartis
India
Lucentis
biosimilars
Interview - Cipla expects to double sales of respiratory drugs by 2020
Yahoo/Reuters
Wed, 06/17/15 - 10:12 am
Cipla
India
respiratory health
asthma
generics
Roche slashes hep C drug price 65% for government clinics in India
Fierce Pharma Asia
Mon, 06/15/15 - 09:00 pm
India
Roche
hepatitis C
drug pricing
India takes first step towards regulating medical devices
Mass Device
Mon, 06/15/15 - 09:38 am
India
devices
regulation
India competition body cracks down on GSK, Sanofi
Fierce Vaccines
Thu, 06/11/15 - 12:06 pm
India
GSK
Sanofi
Aspen to Sell Two Drugs Groups to Strides for $301 Million
Bloomberg
Thu, 05/21/15 - 08:49 am
Aspen Pharmacare
Strides Arcolab
Africa
India
M&A
Australia
Merck scores victory in India patent battle over top diabetes meds
Fierce Pharma
Fri, 05/15/15 - 11:03 am
Merck
India
patents
diabetes
Glenmark
Januvia
Janumet
Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A - bankers
Yahoo/Reuters
Tue, 04/28/15 - 09:53 am
Sun Pharma
India
Ranbaxy
M&A
Mylan's generic Sovaldi launches in India
Medical Marketing and Media
Thu, 04/23/15 - 07:57 pm
Mylan
Sovaldi
India
generics
Gilead Sciences
FDA Scolds Another Indian Drug Maker for Quality Control Problems
WSJ Pharmalot
Thu, 03/26/15 - 07:35 am
FDA
India
drug manufacturing
Aarti Drugs
Sun Pharma open to large acquisitions post Ranbaxy
Yahoo/Reuters
Wed, 03/25/15 - 04:47 pm
Sun Pharma
India
M&A
Ranbaxy
Panel in India recommends waiving late-stage trials for some drugs
Yahoo/Reuters
Thu, 03/5/15 - 09:44 am
India
clinical trials
Natco Pharma ties up with Gilead on hepatitis C drugs
Yahoo/Reuters
Mon, 03/2/15 - 08:09 am
Gilead Sciences
Natco
hepatitis C
India
Sovaldi
Budget 2015: R&D activities in pharma (in India) may get a tax boost
Times of India, India
Wed, 02/25/15 - 09:52 am
R&D
India
Mylan, Gilead in deal for Hepatitis C medications in India
Bizjournals.com
Mon, 02/23/15 - 09:47 am
Mylan Labs
Gilead Sciences
India
hepatitis C
Sovaldi
Harvoni
Lupin says FDA raises concerns over plant at Pithampur
Yahoo/Reuters
Mon, 02/23/15 - 09:36 am
India
Lupin
FDA
drug manufacturing
Indian pharma giants scuffle to snap up injectables maker Claris
BioPharma Dive
Fri, 02/13/15 - 10:30 am
India
injectables
M&A
Claris Lifesciences
Lupin
Cipla
Zydus Cadilla
Pfizer

Pages